Vaccine

Article	Citations
Editorial Board/Aims and Scope	815
Referring to: Wilkinson K, Righolt CH, Elliott LJ, Fanella S, Mahmud SM. Pertussis vaccine effectiveness and duration of protection – a systematic review and meta-analysis. Vaccine. 2021 May 27;39(23)	388
RelCoVax®, a two antigen subunit protein vaccine candidate against SARS-CoV-2 induces strong immune responses in mice	338
Pre-implementation evaluation for an HPV vaccine provider communication intervention among primary care clinics	216
List of abbreviations and acronyms used in Vaccine Value Profiles	193
A non-toxic recombinant bivalent chimeric protein rETXm3CSAm4/TMD as a potential vaccine candidate against enterotoxemia and braxy	190
A phase 3, multicenter, randomized, double-blind study to evaluate the interchangeability of V114, a 15-valent pneumococcal conjugate vaccine, and PCV13 with respect to safety, tolerability, and immun	186
Cost of illness due to pertussis in adults ≥50 years of age in the United Kingdom	178
COVID-19 vaccination in the Federal Bureau of Prisons, December 2020—April 2021	167
Editorial Board/Aims and Scope	156
Editorial Board/Aims and Scope	149
Pseudovirus nanoparticles targeting the receptor binding HA1 domains of influenza viruses elicited high HA1-specific antibody responses and protected mice against mortality caused by influenza virus c	145
Raman spectroscopy as a tool for detection of lung cancer and verification of vaccination effect – Correlation with biochemical data	143
Navigating the future of vaccination strategies: Insights from the 17th annual vaccine congress	135
Editorial Board	129
Editorial Board/Aims and Scope	127
Editorial Board/Aims and Scope	124
Supply, then demand? Health expenditure, political leanings, cost obstacles to care, and vaccine hesitancy predict state-level COVID-19 vaccination rates	120
Impact of vitamin D3 supplementation on COVID-19 vaccine response and immunoglobulin G antibodies in deficient women: A randomized controlled trial	116
Characterization of humoral response to COVID mRNA vaccines in multiple sclerosis patients on disease modifying therapies	111
Reverse vaccinology: A strategy also used for identifying potential vaccine antigens in poultry	103
Adjuvant-dependent impacts on vaccine-induced humoral responses and protection in preclinical models of nasal and genital colonization by pathogenic Neisseria	94
Real-world evidence of yellow Fever vaccination data-driven study	93
Prolonged immune response to tick-borne Ehrlichia chaffeensis infection using a genetically modified live vaccine	93
Long-term antibody trajectories after PPSV23 in elderly: Results from a 4-year follow-up study	93

Protection against tuberculosis by vaccination of secreted chorismate mutase (Rv1885c) combined with a hepatitis B virus (HBV)-derived peptide, Poly6, and alum adjuvants	92
A universal live vaccine platform against multiple serotypes Streptococcus suis based on polyvalent antigen protein	92
Meeting summary: Global vaccine and immunization research forum, 2023	87
Enhanced immunogenicity of a BoHV-1 gG-/tk- vaccine	87
Implementation of mid-adult HPV vaccination guidelines into clinical practice	86
Modelling the impact and cost-effectiveness of upcoming Zika virus vaccines on congenital Zika syndrome	86
Population seroprotection against hepatitis a virus in Israel 18 years after introduction of inactivated vaccine into the routine childhood vaccination schedule: Response letter, to letter to the edit	81
Editorial Board/Aims and Scope	81
Editorial Board/Aims and Scope	80
Linking cohort data and Welsh routine health records to investigate children at risk of delayed primary vaccination	80
Beyond the numbers: An in-depth look at Cameroon's fifth national COVID-19 vaccination campaign through geographical and gender lenses	79
Country immunization policies for refugees across 20 low-middle income and 20 high-income countries	76
Assessing the risks of current COVID-19 challenge trials systematically	75
Cost-effectiveness of routine COVID-19 adult vaccination programmes in England	75
Designing a National Rapid Vaccine Coverage Survey in low-resource settings: Experiences from the Democratic Republic of the Congo 2018–2023	75
COVID-19 and influenza vaccine Hesitancy among adults hospitalized in the United States, 2019–2022	75
Effectiveness of BNT162b2 XBB.1.5 vaccine in immunocompetent adults using tokenization in two U.S. states	74
Dynamics of global emergency vaccine stockpiles: A systems analysis and application to cholera	73
A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine	72
Determinants of seasonal influenza vaccination uptake, intention and recommendations among Lebanese physicians	70
Editorial Board	68
Development of a genetically modified full-length human respiratory syncytial virus preF protein vaccine	68
Significant gaps in hepatitis B vaccination in adults in Viet Nam: Important targets toward hepatitis B elimination by 2030	66
In vitro evaluation of multi-protein chimeric antigens in effectively clearing the blood stage of Plasmodium falciparum	66
Development of COVID-19 vaccine policy — United States, 2020–2023	65
Age, gender and socioeconomic disparities in human papillomavirus (HPV) awareness and knowledge among Japanese adults after a 7-year suspension of proactive recommendation for the HPV vaccine: A natio	65
Editorial Board/Aims and Scope	65
Parental plans to vaccinate children for COVID-19 in New York city	63
Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda	62
COVID-19 adenovirus vector vaccine induces higher interferon and pro-inflammatory responses than mRNA vaccines in human PBMCs, macrophages and moDCs	62
Immunogenicity and safety of hepatitis B vaccination in patients with type 2 diabetes in China: An open-label randomized controlled trial	62
Impact of pneumococcal conjugate vaccination on pneumococcal nasopharyngeal carriage in the Gambia: Population-based cross-sectional surveys	62
COVID-19 vaccine hesitancy among persons living in homeless shelters in France	62
Disparities in Human Papillomavirus vaccination coverage among adolescents in Australia: A geospatial analysis	61
Novel TLR4 adjuvant elicits protection against homologous and heterologous Influenza A infection	61
How can we improve the acceptability of vaccination against Human Papillomavirus (HPV) in France? An original qualitative study with focus groups comprising parents and school staff, interviewed separ	61
Understanding predictors of pneumococcal vaccine uptake in older adults aged 65 years and older in high-income countries across the globe: A scoping review	60
Myocarditis and/or pericarditis risk after mRNA COVID-19 vaccination: A Canadian head to head comparison of BNT162b2 and mRNA-1273 vaccines	60
National introduction of human papillomavirus (HPV) vaccine in Tanzania: Programmatic decision-making and implementation	60
Using geographic information system to track children and optimize immunization coverage and equity in Karachi, Pakistan	60
Editorial Board/Aims and Scope	59
Editorial Board/Aims and Scope	58
Pacific Eclipse: Before the corona dawn	58
Development of a platform-based approach for the clinical production of HIV gp120 envelope glycoprotein vaccine candidates	56
A humanized monoclonal antibody targeting protein a promotes opsonophagocytosis of Staphylococcus aureus in human umbilical cord blood	56
A user-centered approach to developing a new tool measuring the behavioural and social drivers of vaccination	55
Parental health beliefs, intention, and strategies about covid-19 vaccine for their children: A cross-sectional analysis from five Arab countries in the Middle East	55
Immunogenicity and protective efficacy of a trimeric full-length S protein subunit vaccine for porcine epidemic diarrhea virus	55
Cost-effectiveness of human papillomavirus vaccination in girls living in Latin American countries: A systematic review and meta-analysis	55
Humoral response to different SARS-CoV-2 vaccines in orthotopic liver transplant recipients	54

Timeliness in the uptake of hepatitis B birth dose among Indian children under age five: A population-based study	53
Editorial Board/Aims and Scope	53
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infection	53
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo	53
Comparison of the effectiveness and duration of anti-RBD SARS-CoV-2 IgG antibody response between different types of vaccines: Implications for vaccine strategies	52
Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received tw	52
Understanding reporting practices and perceptions of barriers in adverse events following immunisation surveillance: A cross–sectional survey of paediatricians in Kerala, India	51
Inequalities in coverage of COVID-19 vaccination: A population register based cross-sectional study in Wales, UK	51
Acute respiratory distress syndrome (ARDS) as an adverse event following immunization: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data	50
The efficient development of a novel recombinant adenovirus zoster vaccine perfusion production process	50
General vaccination willingness and current vaccination status in relation to clinical and psychological variables in patients with multiple sclerosis	49
Dynamics of multisystem inflammatory syndrome in children associated to COVID-19 in Chile: Epidemiologic trends during pandemic, before and after children vaccination	49
Intranasal administration of a live-attenuated recombinant newcastle disease virus expressing the SARS-CoV-2 Spike protein induces high neutralizing antibody levels and protects from experimental chal	49
COVID-19 vaccine confidence and reasons for vaccination among health care workers and household members	48
Generation and characterization of a genetically modified live rabies vaccine strain with attenuating mutations in multiple viral proteins and evaluation of its potency in dogs	48
Policy and practice of checking vaccination status at school in 2018, a global overview	47
Pacific Eclipse exercise: Value to US Indo-Pacific Command Surgeon’s Office	46
Editorial Board/Aims and Scope	46
Neutralization of Omicron subvariants BA.1 and BA.5 by a booster dose of COVID-19 mRNA vaccine in a Japanese nursing home cohort	45
A comparison of two Fendrix hepatitis B vaccination schedules in patients with inflammatory bowel disease	45
Editorial Board/Aims and Scope	45
Acute reactions after a homologous primary COVID-19 vaccination series: Analysis of Taiwan V-Watch data	44
Modeling the optimal seasonal monoclonal antibody administration strategy for respiratory syncytial virus (RSV) prevention based on age-season specific hospitalization rate of RSV in Suzhou, China, 20	44
Factors associated with humoral immune response in older adults who received egg-free influenza vaccine	44
COVID-19 vaccine hesitancy: Lessons from Israel	44
HPV vaccine: Expanding indications and global disparity	43
Clinical endpoints to inform vaccine policy: A systematic review of outcome measures from pediatric influenza vaccine efficacy trials	43
Second dose of the BNT162b2 mRNA vaccine: Value of timely administration but questionable necessity among the seropositive	43
Integrating the person-centered approach with the study of vaccine hesitancy: Applying latent profile analysis to identify vaccine hesitancy subpopulations and assess their relations with correlates a	43
Editorial Board/Aims and Scope	43
Uptake of COVID-19 vaccines among healthcare workers and the effect of nudging interventions: A mixed methods study	43
The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic	43
Anti-SARS-CoV-2 RBD IgG responses in convalescent versus naïve BNT162b2 vaccine recipients	43
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variants	43
Trend of immunity against measles and varicella zoster virus in healthcare workers in Korea	42
Effect of early life antibiotic use on serologic responses to oral rotavirus vaccine in the MAL-ED birth cohort study	42
Conspiracies, misinformation and resistance to public health measures during COVID-19 in white nationalist online communication	42
Multi-domain narrative review of vaccine hesitancy in childhood	42
Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection	42
Uptake of influenza, pneumococcal and herpes zoster vaccines among people with heart failure and atrial fibrillation	42
A Phase 1, double-blind, randomized, placebo-controlled study to evaluate the safety and immunogenicity of a tetravalent live attenuated dengue vaccine in adults	42
Application of a Neisseria meningitidis antigen microarray to identify candidate vaccine proteins from a human Phase I clinical trial	41
Editorial Board/Aims and Scope	41
Understanding the role of personal experiences and contextual variables in shaping risk reduction preferences	41
Serum vibriocidal responses when second doses of oral cholera vaccine are delayed 6 months in Zambia	41
Short term safety of BNT162b2 (Pfizer–BioNTech) SARS-CoV-2 vaccine among children aged 5–11 years, a nationwide parental survey	41
Community-based hospitals: New partners for government-sponsored clinical research during public health emergencies	41
Laser-facilitated epicutaneous immunization of mice with SARS-CoV-2 spike protein induces antibodies inhibiting spike/ACE2 binding	41
Aiming too high: Shoulder injury related to vaccine administration (SIRVA): A case series	40
Human papillomavirus vaccination receipt and provider counseling rates among high-risk patients	40
Liposomal co-encapsulation of a novel gemini lipopeptide and a CpG-ODN induces a strong Th1 response with the co-activation of a Th2/Th17 profile and high antibody levels	40
NGS method by library enrichment for rapid pestivirus purity testing in biologics	40
Placing a value on increased flexible vaccine manufacturing capacity for future pandemics	40
Live attenuated vaccine efficacy six months after intravenous immunoglobulin therapy for Kawasaki disease	39
Spontaneous reports of primary ovarian insufficiency after vaccination: A review of the vaccine adverse event reporting system (VAERS)	39
Sublingual immunisation with GBS serotype III capsular polysaccharide-tetanus toxoid conjugate vaccine induces systemic and mucosal antibody responses which are opsonophagocytic and inhibit GBS coloni	39
Reactivity characterization of bromoacetyl derivatized polyribosylribitol polysaccharide in Haemophilus influenzae type b for PedvaxHIB® by NMR spectroscopy	39
Ethics of age de-escalation in pediatric vaccine trials: Attending to the case of COVID-19	38
Subcutaneous nodule at the vaccine injection site – A case of mistaken identity	38
Sustained antibody persistence for at least 15 years after a booster vaccination against tick-borne encephalitis following different primary vaccination schedules: Third 5-year follow-up	38
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452	38
Impact of COVID vaccine and comorbidities in patients receiving casirivimab-imdevimab monoclonal antibody during SARS-CoV-2 B.1.617.2 (Delta) surge: A real-world study	38
Editorial Board	38
Influenza vaccination in children with pulmonary disease during the COVID-19 pandemic	37
Reassurance of population immunity to diphtheria in England: Results from a 2021 national serosurvey	37
Editorial Board/Aims and Scope	37
Editorial Board/Aims and Scope	37
Analyzing an immunization resource website: User browsing trends	37
Complementary medicine use and flu vaccination – A nationally representative survey of US adults	37
Immunogenicity and protective efficacy of SARS-CoV-2 recombinant S-protein vaccine S-268019-b in cynomolgus monkeys	36
Letter to the editor	36
Enhancement of live vaccines by co-delivery of immune modulating proteins	36
Prevalence of indications for adult hepatitis A vaccination among hepatitis A outbreak-associated cases, Three US States, 2016–2019	36
Previous biological therapy and impairment of the IFN-γ/IL-10 axis are associated with low immune response to 17DD-YF vaccination in patients with spondyloarthritis	36
Editorial Board/Aims and Scope	36
Association between Covishield vaccine and menstrual disturbance. Findings from a cross-sectional study among participants of Zero TB cohort in India	36
Editorial Board/Aims and Scope	36
Managing multiplicity in clinical vaccine studies – A case study using a gatekeeping testing strategy	36
Sexual orientation was associated with intention to be vaccinated with a smallpox vaccine against mpox: A cross-sectional preliminary survey in Japan	36
The safety of seasonal influenza vaccination among adults prescribed immune checkpoint inhibitors: A self-controlled case series study using administrative data	36

Literature review to identify evidence of secondary transmission of pentavalent human-bovine reassortant rotavirus vaccine (RV5) strains to unvaccinated subjects	36
Trust and science: Public health’s home field advantage in addressing vaccine hesitancy and improving immunization rates	35
Editorial Board/Aims and Scope	35
Editorial Board/Aims and Scope	35
Burden of rotavirus disease in young children in Iceland – Time to vaccinate?	34
Association between vaccination status, symptom identification and healthcare use: Implications for test negative design observational studies	34
Childhood vaccination timeliness following maternal migration to an informal urban settlement in Kenya	34
Mass vaccination campaign during the 2016 influenza outbreak in Panama: Challenges and implications for COVID-19 vaccination efforts	34
Editorial Board/Aims and Scope	34
BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunity	33
The second annual Vaccination Acceptance Research Network Conference (VARN2023): Shifting the immunization narrative to center equity and community expertise	33
Preventing erosion of oral polio vaccine acceptance: A role for vaccinator visits and social norms	33
Broad neutralization against SARS-CoV-2 variants induced by ancestral and B.1.351 AS03-Adjuvanted recombinant Plant-Derived Virus-Like particle vaccines	33
Effectiveness of the varicella vaccine in the real world, a matched case-control study	33
Persistent differences in the immunogenicity of the two COVID-19 primary vaccines series, modulated by booster mRNA vaccination and breakthrough infection	33
Evaluating the health and economic outcomes of a PCV15 vaccination program for adults aged 65 years-and-above in Switzerland	33
Rift Valley Fever vaccine strategies: Enhanced stability of RVF Clone 13	33
Evaluation of dynamics of immune responses and protective efficacy in piglets immunized with an inactivated porcine reproductive and respiratory syndrome vaccine candidate	33
Role of rotavirus vaccine in reducing diarrheal episodes in infants visiting private primary health care clinics in Karachi, Pakistan: A mixed-methods study	33
A J Paramyxovirus-vectored HIV vaccine induces humoral and cellular responses in mice	32
Mumps to COVID-19: Vaccinated persons remain vulnerable when community uptake is low	32
A multicenter study on the epidemiology of complicated parapneumonic effusion in the era of currently available pneumococcal conjugate vaccines	32
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis	32
Characterization of gH/gL/pUL128-131 pentameric complex, gH/gL/gO trimeric complex, gB and gM/gN glycoproteins in a human cytomegalovirus using automated capillary western blots	31
UK healthcare professionals’ attitudes towards the introduction of varicella vaccine into the routine childhood vaccination schedule and their preferences for administration	31
Beyond the polysaccharide and glycoconjugate vaccines for Streptococcus pneumoniae: Does protein/peptide nanovaccines hold promises?	31
Human papillomavirus (HPV) vaccine coverage rates (VCRs) in France: A French claims data study	31
Building leadership and management competencies of national immunization teams in 16 Gavi-eligible countries through the EPI leadership and management programme	31
NIH funding for vaccine readiness before the COVID-19 pandemic	31
Advax-CpG55.2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants	31
COVID-19 vaccination hesitancy in people affected by diabetes and strategies to increase vaccine compliance: A systematic narrative review and meta-analysis	30
Estimating the cost of COVID-19 vaccine deployment and introduction in Ghana using the CVIC tool	30
Live attenuated Bordetella pertussis vaccine candidate BPZE1 transiently protects against lethal pneumococcal disease in mice	30
Cardiac events following JYNNEOS vaccination for prevention of Mpox	30
COVID-19 vaccination intention and activation among health care system employees: A mixed methods study	29
Cost-benefit of influenza vaccination in preventing sudden cardiac arrest amongst Australian adults	29
Increasing acceptance of a vaccination program for coronavirus disease 2019 in France: A challenge for one of the world’s most vaccine-hesitant countries	29
Multisystem inflammatory syndrome in children (MIS-C) cases by vaccination status in California	29
Editorial Board/Aims and Scope	29
How to accelerate the supply of vaccines to all populations worldwide? Part II: Initial industry lessons learned and detailed technical reflections leveraging the COVID-19 situation	29
Immune non-interference and safety study of Vi-DT typhoid conjugate vaccine with a measles, mumps and rubella containing vaccine in 9–15 months old Nepalese infants	29
Anti-SARS-CoV-2 cellular response after 2 and 3 doses of BNT162b2 mRNA vaccine in lymphoma patients receiving anti-CD20 antibodies	29
COVID-19 vaccination attitudes, values and intentions among United States adults prior to emergency use authorization	29
Inclusion of intersectionality in studies of immunization uptake in Canada: A scoping review	29
Projections of the incidence of COVID-19 in Japan and the potential impact of a Fall 2023 COVID-19 vaccine	28
A retrospective analysis of social media posts pertaining to COVID-19 vaccination side effects	28
Can risk area designation help increase vaccination coverage for Tick-Borne Encephalitis? Evidence from German claims data	28
Immunization and challenge trials in a murine model using different inactivated recombinant vaccines against H1N1 swine influenza virus circulating in Brazil	28
Post-exposure prophylaxis for the prevention of measles: A systematic review	28
MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings	28
Costs of delivering human papillomavirus vaccination using a one- or two-dose strategy in Tanzania	28
Cost-effectiveness of anti-viral treatment for infants with RSV disease in the United Kingdom	28
A framework for monitoring RSV prevention product effectiveness in the United States	28
Changes in population genetic structure of serotype 19A Streptococcus pneumoniae after universal childhood use of the 10-valent pneumococcal conjugate vaccine in Brazil	28
Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S	28
Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.	28
Burden of pertussis among young infants in Malaysia: A hospital-based surveillance study	28
Corrigendum to Assessment of the Bnt162b2 covid-19 vaccine immune response in Brazilian indigenous adolescents. Vaccine Volume 43, Part 1, 1 January 2025, 126494	28
Immunogenicity of yellow fever vaccine co-administered with 13-valent pneumococcal conjugate vaccine in rural Gambia: A cluster-randomised trial	28
Political quarrel overshadows vaccination advocacy: How the vaccine debate on Brazilian Twitter was framed by anti-vaxxers during Bolsonaro administration	27
A new H9 influenza virus mRNA vaccine elicits robust protective immunity against infection	27
Supporting immunization programs to address COVID-19 vaccine hesitancy: Recommendations for national and community-based stakeholders	27
Presence of defective viral genes in H1N1 live attenuated influenza vaccine strains is not associated with reduced human cell fitness or vaccine effectiveness	27
Challenges, best practices, and lessons learned from oral cholera mass vaccination campaign in urban Cameroon during the COVID-19 era	27
Sex and age as determinants of the seroprevalence of anti-measles IgG among European healthcare workers: A systematic review and meta-analysis	27
Closing the gap on vaccine uptake in developing countries: Is there a role for cash incentives?	27
Richard Pfeiffer’s typhoid vaccine and Almroth Wright’s claim to priority	27
Disproportionality analysis of reported drug adverse events to assess a potential safety signal for pentavalent vaccine in 2019 in El Salvador	27
Barriers to influenza vaccination during pregnancy in France: A national population-based study	27
Regional differences in provider recommendation of HPV vaccines among 13-to-17 year old adolescents from 2019 to 2021	27
Mapping the timeliness of routine childhood vaccination in The Gambia: A spatial modelling study	27
BCG-induced immunity profiles in household contacts of leprosy patients differentiate between protection and disease	27
Modelling control strategies for pneumococcal meningitis outbreaks in the African meningitis belt	27
Improved childhood immunization coverage using the World Health Organization’s Tailoring Immunization Programmes guide (TIP) in a regional centre in Australia	27
Antibody response to non-mRNA SARS-CoV-2 vaccine in kidney transplant recipients	27
Conversational artificial intelligence: A new approach for increasing influenza vaccination rates in children with asthma?	26
Immunological implications of diverse production approaches for Chikungunya virus-like particle vaccines	26
Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort study	26
Comparative effectiveness of mandates and financial policies targeting COVID-19 vaccine hesitancy: A randomized, controlled survey experiment	26
Editorial Board	26
Evaluation of the decision-making process underlying the initial off-label use of vaccines: A scoping review	26
Complement-mediated killing of Mycoplasma bovis does not play a role in the protection of animals against an experimental challenge	26
Conceptual debates in the study of canine & feline vaccine hesitancy: A response to Haeder 2023	26
The effectiveness of vaccines against COVID-19 in Mexico: A time series approach	26
Mumps resurgence in a highly vaccinated population: Insights gained from surveillance in Canada, 2002–2020	26
Parental hesitancy about COVID-19, influenza, HPV, and other childhood vaccines	26
Quantitation and characterization of serotype 6A activation for pneumococcal conjugate vaccine by cryo-EM and SEC methods	26
Immunoprotective efficacy of Escherichia coli-derived outer membrane vesicles displaying PlpE protein of Pasteurella multocida	26
100 years of the Bacillus Calmette-Guérin vaccine	25
Factors associated with the intention to participate in COVID-19 vaccine clinical trials: A cross-sectional study in Peru	25
Letter to the editor: SARS-CoV-2 vaccination in children and adolescents with neurodevelopmental or psychiatric disorders	25
The safety and immunogenicity of an inactivated SARS-CoV-2 vaccine in Chinese adults aged 18–59 years: A phase I randomized, double-blinded, controlled trial	25
“Fighting the pandemic!” Western Australian pharmacists’ perspectives on COVID-19 vaccines: A qualitative study	25
Unmethylated CpG motif-containing genomic DNA fragments of bacillus calmette-guerin improves immune response towards a DNA vaccine for COVID-19	25
Changes in childhood vaccination during the coronavirus disease 2019 pandemic in Japan	25